XML 34 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1

Accrued Expenses and Other Current Liabilities (Tables)

3 Months Ended

Mar. 31, 2018

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:

	As of
	March 31, 2018				December 31, 2017
Bonus	$	454,494			$	2,538,340
Deferred revenue-R&D for TPOXX® intravenous formulation	1,255,318				1,255,318
Professional fees	405,096				381,980
Vacation	361,755				328,588
Other (primarily R&D vendors and CMOs)	1,109,532				977,353
Accrued expenses and other current liabilities	$	3,586,195			$	5,481,579

X

- Definition

Tabular disclosure of the components of accrued liabilities and other current liabilities.

+ References

No definition available.

+ Details

Name:	siga_AccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock
Namespace Prefix:	siga_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration